Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2006 16:15 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Seek Orphan Drug Status and Begin Development of Droxidopa for Neurogenic Orthostatic Hypotension

Management to Host Conference Call to Discuss New Product and Update Investors on Clinical Development of Expanded Pipeline CHARLOTTE, N.C., May 8, 2006 (PRIMEZONE) -- Chelsea...
May 01, 2006 08:25 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Obtains NASDAQ Listing Approval

CHARLOTTE, N.C., May 1, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (OTCBB:CHTP) has obtained written approval from NASDAQ for its common stock to begin trading on The NASDAQ Capital...
March 08, 2006 08:00 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at Sachs Associates North American Biotech Forum

CHARLOTTE, N.C., March 8, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (OTCBB:CHTP), announced today that President and CEO, Dr. Simon Pedder, will be presenting at the Sachs...
January 23, 2006 09:50 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at Friedland Undervalued Equities Conference

CHARLOTTE, N.C., Jan. 23, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (OTCBB:CHTP), is scheduled to present at the Friedland Undervalued Equities Conference at 10:35 a.m. ET,...
December 21, 2005 09:35 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Reports Positive Preliminary Results From Phase Ib Trial of CH-1504

CHARLOTTE, N.C., Dec. 21, 2005 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (OTCBB:CHTP) has successfully completed the Phase Ib trial of its leading drug candidate, CH-1504, an orally...
November 10, 2005 09:59 ET | Source: Chelsea Therapeutics

Lead Investigator to Present Positive Clinical Study Results for Chelsea Therapeutics' Lead Compound CH-1504 at ACR 2005 Annual Scientific Meeting

CHARLOTTE, N.C., Nov. 10, 2005 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (OTCBB:CHTP) announced that Dr. Oswaldo Castaneda will present results of a pilot clinical trial of the...
November 01, 2005 08:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference

CHARLOTTE, N.C., Nov. 1, 2005 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (OTCBB:CHTP), has accepted an invitation to speak at the Rodman & Renshaw Techvest 7th Annual Healthcare...
October 20, 2005 08:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Completes Phase Ia Trial of CH-1504

CHARLOTTE, N.C., Oct. 20, 2005 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (OTCBB:CHTP), has successfully completed the Phase Ia trial of its leading drug candidate, CH-1504, an orally...
October 18, 2005 15:00 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at 3rd Annual PIPES Conference 2005

CHARLOTTE, N.C., Oct. 18, 2005 (PRIMEZONE) -- Chelsea Therapeutics, Inc. (OTCBB:CHTP) is scheduled to present at the Third Annual PIPEs Conference 2005 being held in New York City at The...
October 18, 2005 08:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present At C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference

CHARLOTTE, N.C., Oct. 18, 2005 (PRIMEZONE) -- Chelsea Therapeutics, Inc. (OTCBB:CHTP) will present at the C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference at 10:00 AM EDT, Wednesday,...